Defunct Company
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
555
NCT01348451
Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Dec 31, 2016
NCT01310881
Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
Start: Feb 28, 2011
Completion: Nov 30, 2011
NCT01520649
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Start: May 31, 2012
Completion: Feb 28, 2014
NCT01730716
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Phase: Phase 2
Start: May 31, 2013
Completion: Nov 30, 2016
NCT01772810
Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Start: Aug 31, 2014
Completion: Dec 31, 2022
NCT02695472
Study of NSI-189 for Major Depressive Disorder
Start: Mar 31, 2016
Completion: Dec 31, 2017
NCT02724735
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
Phase: N/A
Start: Aug 31, 2016
Completion: Jan 31, 2018
NCT04159584
Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD
Role: Collaborator
Start: Apr 15, 2019
Completion: Sep 11, 2019